Terms: = Liver cancer AND SEPT5, HCDCREL-1, 5413, ENSG00000184702, Q99719, PNUTL1, H5 AND Treatment
4 results:
1. The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway.
Yang Q; Liang Y; Shi Y; Shang J; Huang X
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15499-15510. PubMed ID: 37646828
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical application value of prognosis of nutrition index and apparent diffusion coefficient in patient with hepatocellular carcinoma underwent transarterial chemoembolization].
Sun WH; Zhang AD; Li W
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(33):2581-2585. PubMed ID: 31510716
[No Abstract] [Full Text] [Related]
3. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
[TBL] [Abstract] [Full Text] [Related]
4. Effect of hepatocyte growth factor/scatter factor and other growth factors on motility and morphology of non-tumorigenic and tumor cells.
Li Y; Bhargava MM; Joseph A; Jin L; Rosen EM; Goldberg ID
In Vitro Cell Dev Biol Anim; 1994 Feb; 30A(2):105-10. PubMed ID: 7516797
[TBL] [Abstract] [Full Text] [Related]
